Chiome will use its Autonomously Diversifying Library (ADLib) technology to generate mAbs for cancer company OncoMed

Chiome Bioscience Inc.

Japan / Tools, Services, and Manufacturing

$118.9m on 12/30/2011 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

OncoMed Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced